Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abolishing, acneiform, agonism, agonist, arm, backbone, bivalent, bronchial, bypassing, Cluster, compartment, concordance, confirmed, consecutive, customary, delist, delisting, Differentiation, distinct, East, engineered, Fc, format, Immunotherapy, infiltrating, inflammatory, letter, low, mediated, Middle, molecule, monovalent, myeloid, notable, notifying, oAs, obstruction, oFollowing, oWhile, paragraph, pathway, pH, poster, prototype, provisionally, receptor, regain, signaling, SITC, Society, stymied, toxicity, unanimously
Removed:
highest, poor, unleash
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view